Trial
NCT03960554
The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Thomas Nickolas, MD MS
Collaborators
—
Condition
Osteoporosis
Intervention
Denosumab Inj 60 mg/ml
Why stopped
Study lost funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-25